0,869  0,003  Sensitization
0,868  0,004  Antihypercholesterolemic
0,816  0,009  Caspase 9 stimulant
0,811  0,014  Antiinflammatory
0,713  0,004  UGT1A4 substrate
0,704  0,030  Apoptosis agonist
0,663  0,005  Antipruritic, allergic
0,614  0,017  Cholesterol antagonist
0,602  0,008  Antipyretic
0,614  0,029  Transcription factor NF kappa B inhibitor
0,583  0,003  Potassium channel large-conductance Ca-activated activator
0,567  0,014  Hepatic disorders treatment
0,563  0,015  Chemopreventive
0,578  0,031  Antidiabetic
0,578  0,031  Cyclophilin D inhibitor
0,575  0,029  TNF expression inhibitor
0,547  0,003  Potassium channel (Ca-activated) activator
0,555  0,014  Lipoprotein disorders treatment
0,547  0,008  UGT1A1 substrate
0,548  0,014  Antipsoriatic
0,539  0,006  UGT2B4 substrate
0,533  0,003  Gastrin inhibitor
0,530  0,017  AR expression inhibitor
0,516  0,004  UGT2B7 substrate
0,517  0,012  UGT1A6 substrate
0,511  0,009  Antihypoxic
0,532  0,030  CYP2C9 substrate
0,505  0,005  Abortion inducer
0,516  0,018  UGT1A9 substrate
0,502  0,007  UGT1A3 substrate
0,491  0,003  UGT2B9 substrate
0,506  0,021  Antineoplastic (pancreatic cancer)
0,478  0,005  UGT2B1 substrate
0,484  0,014  Hypolipemic
0,500  0,032  Atherosclerosis treatment
0,466  0,004  Antipruritic, non-allergic
0,467  0,007  Prostate disorders treatment
0,465  0,009  Hair growth stimulant
0,489  0,033  Histamine release inhibitor
0,467  0,014  Antineoplastic (endocrine cancer)
0,474  0,023  NOS3 expression inhibitor
0,477  0,033  Stroke treatment
0,451  0,008  Interferon gamma antagonist
0,450  0,009  Non-steroidal antiinflammatory agent
0,480  0,042  Antiobesity
0,446  0,009  Prostatic (benign) hyperplasia treatment
0,446  0,017  Antihypertriglyceridemic
0,439  0,012  Anesthetic general
0,446  0,020  Nitric oxide antagonist
0,428  0,004  Antiinfertility, female
0,440  0,017  Vascular (periferal) disease treatment
0,431  0,008  Antiacne
0,425  0,004  ABCA1 expression enhancer
0,426  0,011  Contraceptive
0,415  0,002  Ornithine decarboxylase inhibitor
0,457  0,045  Immunosuppressant
0,459  0,049  CYP3A4 substrate
0,414  0,006  Antiviral (Influenza A)
0,443  0,037  Respiratory analeptic
0,407  0,002  Liver X receptor alpha agonist
0,416  0,012  Antiparkinsonian, rigidity relieving
0,414  0,013  Sodium/bile acid cotransporter inhibitor
0,408  0,010  Antiviral (Influenza)
0,450  0,054  Antineoplastic (lung cancer)
0,426  0,033  Cardioprotectant
0,401  0,008  UGT2B15 substrate
0,434  0,044  Ulceration
0,454  0,065  Antineoplastic (breast cancer)
0,392  0,005  Cholesterol synthesis inhibitor
0,418  0,031  Chemoprotective
0,428  0,042  Bone diseases treatment
0,410  0,029  Antidiabetic (type 2)
0,401  0,022  Acute neurologic disorders treatment
0,412  0,035  Antiepileptic
0,409  0,036  Apoptosis antagonist
0,411  0,049  Prostate cancer treatment
0,401  0,041  CYP2C19 substrate
0,398  0,038  Antiosteoporotic
0,371  0,011  Lipocortins synthesis antagonist
0,389  0,029  Hypoglycemic
0,385  0,026  Antineoplastic (liver cancer)
0,381  0,023  UDP-glucuronosyltransferase substrate
0,395  0,037  Cytotoxic
0,387  0,034  NOS2 expression inhibitor
0,361  0,014  Anesthetic
0,390  0,044  ICAM1 expression inhibitor
0,405  0,062  Antileukemic
0,352  0,010  Antiparkinsonian, tremor relieving
0,387  0,046  Teratogen
0,350  0,016  Diuretic
0,371  0,045  Analeptic
0,336  0,011  Interleukin 6 antagonist
0,331  0,009  Antihyperlipoproteinemic
0,365  0,047  Embryotoxic
0,335  0,021  Hepatoprotectant
0,315  0,003  5-Alpha-reductase inhibitor
0,311  0,002  Retinoid X alpha receptor agonist
0,363  0,054  Antineoplastic (ovarian cancer)
0,355  0,052  Antineoplastic (melanoma)
0,335  0,033  Antiulcerative
0,328  0,026  Muscle relaxant
0,318  0,016  Protein-tyrosine phosphatase inhibitor
0,307  0,007  LDLR expression enhancer
0,338  0,038  Myocardial infarction treatment
0,307  0,010  Endometrios treatment
0,336  0,041  Cardiodepressant
0,298  0,005  HDL-cholesterol increasing
0,299  0,006  Contraceptive female
0,344  0,054  Calcium channel activator
0,298  0,011  Protein-tyrosine phosphatase 1B inhibitor
0,367  0,081  CYP2C19 inhibitor
0,301  0,018  Neurotrophic factor enhancer
0,327  0,046  Renal disease treatment
0,317  0,036  Sigma receptor agonist
0,323  0,046  Proliferative diseases treatment
0,278  0,004  Keratolytic
0,294  0,033  Antihelmintic
0,274  0,016  Insulin secretagoues
0,326  0,067  Caspase 3 stimulant
0,260  0,002  Retinoid X receptor agonist
0,314  0,057  Antioxidant
0,306  0,050  Cardiovascular analeptic
0,316  0,063  Interleukin 2 agonist
0,294  0,044  Antiparasitic
0,255  0,005  TRPA1 agonist
0,251  0,003  Liver X receptor beta agonist
0,303  0,057  Antineoplastic (glioma)
0,270  0,026  Skeletal muscle relaxant
0,249  0,005  Actinic keratosis treatment
0,298  0,054  Tumour necrosis factor alpha release inhibitor
0,255  0,012  UGT2B10 substrate
0,252  0,009  SULT1A1 substrate
0,250  0,009  Choleretic
0,261  0,021  Phospholipase A2 inhibitor
0,304  0,064  Hypoxia-inducible factor 1 alpha inhibitor
0,293  0,054  Urologic disorders treatment
0,340  0,108  Antibacterial
0,351  0,119  Antiarthritic
0,239  0,008  Arachidonic acid antagonist
0,247  0,018  Antifungal enhancer
0,277  0,050  Carcinogenic
0,304  0,079  Antifungal
0,236  0,014  Sulfotransferase substrate
0,272  0,051  Psychostimulant
0,246  0,026  Antipruritic
0,229  0,014  Retinoprotector
0,248  0,038  Urinary incontinence treatment
0,300  0,097  Vasodilator, peripheral
0,205  0,002  Liver X receptor beta antagonist
0,238  0,035  Antiviral (Herpes)
0,200  0,003  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,229  0,032  Protein kinase stimulant
0,214  0,018  Farnesoid X receptor antagonist
0,278  0,085  CTGF expression inhibitor
0,203  0,013  Androgen antagonist
0,239  0,053  Wound healing agent
0,190  0,004  Liver X receptor agonist
0,199  0,019  Cyclooxygenase 3 inhibitor
0,185  0,006  Antiviral (SARS coronavirus)
0,185  0,006  Antiviral (Coronavirus)
0,182  0,003  Liver X receptor alpha antagonist
0,263  0,086  Spasmolytic
0,250  0,075  Antineoplastic (cervical cancer)
0,269  0,097  CYP2D6 substrate
0,186  0,015  Pregnane X receptor agonist
0,175  0,005  Glycine receptor agonist
0,189  0,019  Menstruation disorders treatment
0,317  0,147  5 Hydroxytryptamine release inhibitor
0,249  0,080  Interleukin agonist
0,274  0,107  Antithrombotic
0,201  0,035  Antidiarrheal
0,171  0,006  Glutamate release inhibitor
0,167  0,005  Anticholelithogenic
0,202  0,041  Toxic, respiratory center
0,164  0,004  Liver X receptor antagonist
0,163  0,006  Bile acid receptor antagonist
0,261  0,105  Antineoplastic (osteosarcoma)
0,233  0,078  Angiogenesis stimulant
0,171  0,017  AMP-activated protein kinase stimulant
0,178  0,024  Nav1.1 sodium channel blocker
0,168  0,015  Potassium channel activator
0,158  0,005  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,186  0,033  DNA polymerase I inhibitor
0,162  0,012  Anabolic
0,154  0,004  5-Alpha-reductase 2 inhibitor
0,174  0,025  Anticataract
0,157  0,012  UGT2B11 substrate
0,192  0,049  Phospholipase C inhibitor
0,171  0,029  Growth stimulant
0,246  0,104  Antineoplastic (colorectal cancer)
0,241  0,100  Immunostimulant
0,187  0,047  Melanin inhibitor
0,141  0,001  Retinoid X beta receptor antagonist
0,151  0,011  Estrogen receptor alpha antagonist
0,142  0,004  5-Alpha-reductase 1 inhibitor
0,171  0,034  Adenylate cyclase stimulant
0,205  0,070  Sedative
0,162  0,027  Interleukin 8 antagonist
0,190  0,056  Antihelmintic (Nematodes)
0,144  0,014  Aromatase inhibitor
0,233  0,103  Radioprotector
0,173  0,045  SULT1A3 substrate
0,129  0,003  Cholesterol ester transfer protein antagonist
0,136  0,010  Hyperparathyroidism treatment
0,239  0,113  Metabolic disease treatment
0,130  0,004  Heme oxygenase stimulant
0,184  0,060  Antirickettsial
0,139  0,014  CDC25A inhibitor
0,162  0,038  Adenylate cyclase inhibitor
0,190  0,067  Antiviral (Hepatitis)
0,228  0,106  Antineoplastic (colon cancer)
0,280  0,158  Analgesic
0,154  0,031  Alcohol dehydrogenase substrate
0,132  0,010  SULT1A2 substrate
0,191  0,070  P-glycoprotein inhibitor
0,165  0,045  Cocaine dependence treatment
0,128  0,008  Acetyl-CoA transferase inhibitor
0,190  0,072  VEGF expression inhibitor
0,161  0,044  Antieczematic
0,123  0,007  Aldosterone antagonist
0,143  0,026  Estrogen antagonist
0,171  0,055  NOS3 expression enhancer
0,231  0,116  CYP1A2 substrate
0,206  0,092  RNA-directed DNA polymerase inhibitor
0,131  0,024  Paget's disease treatment
0,165  0,058  Lipid peroxidase inhibitor
0,150  0,045  Antitussive
0,109  0,003  Retinoid X gamma receptor agonist
0,123  0,018  3C-Like protease (SARS coronavirus) inhibitor
0,150  0,046  Antihemorrhagic
0,198  0,095  Cyclic AMP phosphodiesterase inhibitor
0,124  0,021  Tocolytic
0,182  0,081  Platelet adhesion inhibitor
0,118  0,018  Na+ K+ transporting ATPase inhibitor
0,158  0,058  CNS active muscle relaxant
0,102  0,002  Retinoid X receptor antagonist
0,201  0,104  Aldehyde oxidase inhibitor
0,256  0,159  15-Lipoxygenase inhibitor
0,186  0,089  Insulin sensitizer
0,116  0,020  Glycine receptor antagonist
0,232  0,137  Antihypertensive
0,144  0,049  Antiviral (Hepatitis B)
0,117  0,023  Contraceptive male
0,097  0,004  Farnesoid X receptor agonist
0,122  0,030  Estrogen receptor beta antagonist
0,158  0,067  Acaricide
0,106  0,016  Estrogen agonist
0,145  0,056  Antiseptic
0,147  0,059  Psychosexual dysfunction treatment
0,091  0,002  Retinoid X alpha receptor antagonist
0,238  0,151  Inflammatory Bowel disease treatment
0,166  0,079  Mutagenic
0,299  0,214  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,097  0,011  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,105  0,019  Estrogen-related receptor beta agonist
0,160  0,076  Antiviral (Hepatitis C)
0,161  0,078  Muscular dystrophy treatment
0,117  0,034  Lanosterol 14 alpha demethylase inhibitor
0,202  0,120  DNA synthesis inhibitor
0,103  0,021  Cushing's syndrome treatment
0,084  0,004  Retinoid X beta receptor agonist
0,152  0,073  Acute respiratory distress syndrome (ARDS) treatment
0,187  0,108  Antiprotozoal (Leishmania)
0,109  0,031  Transcription factor NF kappa B stimulant
0,210  0,134  5 Hydroxytryptamine uptake stimulant
0,093  0,019  CDC25B inhibitor
0,133  0,059  CC chemokine 6 receptor antagonist
0,164  0,089  Diabetic nephropathy treatment
0,106  0,032  Inducible nitric-oxide synthase inhibitor
0,077  0,004  ATP citrate lysase inhibitor
0,078  0,005  Geranyltranstransferase inhibitor
0,077  0,005  Retinoic acid alpha receptor agonist
0,091  0,019  Androgen agonist
0,133  0,062  Vanilloid 1 agonist
0,113  0,043  Prolactin inhibitor
0,173  0,104  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,129  0,060  Anesthetic local
0,143  0,076  Antidiabetic (type 1)
0,086  0,019  SULT2A1 substrate
0,071  0,005  Alpha 1L adrenoreceptor agonist
0,076  0,013  Acetyl-CoA transferase 2 inhibitor
0,075  0,012  Progesterone antagonist
0,078  0,015  Diacylglycerol O-acyltransferase inhibitor
0,104  0,041  Aminoacyl-tRNA synthetase inhibitor
0,066  0,004  Retinoic acid receptor antagonist
0,139  0,076  Ca2+-transporting ATPase inhibitor
0,081  0,019  Antihemophilic
0,134  0,072  Interleukin 1 antagonist
0,167  0,105  Antineoplastic (glioblastoma multiforme)
0,077  0,016  Postcoital contraceptive
0,077  0,016  Lipocortins synthesis agonist
0,063  0,004  Retinoic acid alpha receptor antagonist
0,068  0,010  RNA-directed RNA polymerase stimulant
0,130  0,071  Liver cirrhosis treatment
0,067  0,009  Glucocorticoid antagonist
0,076  0,019  Calcium channel P-type blocker
0,130  0,073  Nav1.2 sodium channel blocker
0,061  0,005  Retinoic acid receptor agonist
0,179  0,123  Age-related macular degeneration treatment
0,113  0,057  Gout treatment
0,118  0,063  Monophenol monooxygenase inhibitor
0,105  0,050  Tourette's syndrome treatment
0,141  0,087  Eye irritation, high
0,062  0,008  Acetyl-CoA transferase 1 inhibitor
0,105  0,053  Antineoplastic, alkylator
0,253  0,202  Calcium channel L-type activator
0,105  0,056  Hedgehog signaling inhibitor
0,112  0,064  Skin irritative effect
0,170  0,121  Antineoplastic enhancer
0,184  0,136  Superoxide dismutase inhibitor
0,108  0,060  Expectorant
0,075  0,027  Antimycoplasmal
0,050  0,003  Retinoid X gamma receptor antagonist
0,107  0,059  Urease inhibitor
0,056  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,114  0,068  Microtubule formation inhibitor
0,130  0,086  Antimutagenic
0,047  0,003  Retinoic acid beta receptor antagonist
0,062  0,018  Mineralocorticoid receptor antagonist
0,057  0,014  Parathyroid hormone antagonist
0,071  0,029  Transcription factor AP-1 inhibitor
0,046  0,003  Retinoic acid receptor gamma antagonist
0,068  0,027  Postmenopausal disorders treatment
0,083  0,043  Narcotic antagonist
0,189  0,150  Transcription factor STAT3 inhibitor
0,043  0,004  Retinoic acid gamma receptor agonist
0,071  0,032  Hypercalcemia treatment
0,073  0,034  HIV-1 integrase (Strand Transfer) inhibitor
0,140  0,103  Liver fibrosis treatment
0,133  0,096  Thrombolytic
0,039  0,004  Retinoic acid beta receptor agonist
0,039  0,005  Nicotinic acid receptor 2 antagonist
0,071  0,037  Uterine relaxant
0,176  0,143  Antihypotensive
0,055  0,023  Cholesterol esterase inhibitor
0,091  0,061  SULT1E1 substrate
0,115  0,085  Cyclooxygenase 1 inhibitor
0,053  0,023  Estradiol 17 beta-dehydrogenase inhibitor
0,082  0,054  Opioid kappa receptor antagonist
0,148  0,120  Interleukin antagonist
0,052  0,024  Adenylate cyclase 1 inhibitor
0,134  0,107  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,189  0,164  12-Lipoxygenase inhibitor
0,045  0,020  GABA uptake inhibitor
0,066  0,041  Antiemphysemic
0,034  0,008  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,159  0,135  Free radical scavenger
0,038  0,014  Carboxypeptidase B inhibitor
0,161  0,138  Antiviral (HIV)
0,039  0,016  HMG CoA reductase inhibitor
0,115  0,094  Skin whitener
0,100  0,080  Interleukin 1b antagonist
0,063  0,043  Nitric oxide donor
0,057  0,038  Pregnane X receptor antagonist
0,046  0,027  Opioid kappa receptor agonist
0,143  0,126  Succinate dehydrogenase inhibitor
0,070  0,053  Peroxisome proliferator-activated receptor gamma antagonist
0,026  0,009  Vitamin D receptor antagonist
0,041  0,025  AMPA 4 receptor antagonist
0,051  0,034  Prostaglandin E2 antagonist
0,060  0,045  NMDA 2C receptor antagonist
0,039  0,023  Glucose-6-phosphate dehydrogenase inhibitor
0,053  0,039  Sphingosine 1-phosphate receptor 5 agonist
0,026  0,012  Estrone sulfatase inhibitor
0,217  0,203  CYP2C9 inhibitor
0,041  0,028  Cholesterol absorption inhibitor
0,037  0,024  Nicotinic acid receptor agonist
0,024  0,012  Corticosteroid-like
0,065  0,052  Glutamate (mGluR6) antagonist
0,042  0,030  Sphingosine 1-phosphate receptor 1 agonist
0,061  0,049  Leukotriene antagonist
0,144  0,133  Phobic disorders treatment
0,196  0,185  Vasodilator, coronary
0,204  0,193  FMO1 substrate
0,034  0,024  Estrogen receptor alpha agonist
0,028  0,018  Hedgehog signaling activator
0,035  0,026  AMPA receptor agonist
0,031  0,023  Estrogen receptor beta agonist
0,040  0,032  Hypogonadism treatment
0,044  0,036  Potassium channel Kv1.3 blocker
0,059  0,052  Purinergic P2X2 antagonist
0,047  0,040  NMDA 2A receptor antagonist
0,027  0,022  Diacylglycerol O-acyltransferase 1 inhibitor
0,017  0,013  Progesterone agonist
0,033  0,029  Nicotinic acid receptor 2 agonist
0,065  0,061  Dysmenorrhea treatment
0,012  0,010  Glucocorticoid agonist
0,119  0,117  Hemostatic
0,015  0,014  Vitamin D receptor agonist
0,011  0,011  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,085  0,085  Electrolyte absorption antagonist
0,038  0,037  Guanylate cyclase inhibitor

